Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Abraxane
(paclitaxel)
Uses, side effects, dosage information & price range
About this medicine
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
Common Brand Names for this Composition
The following popular commercial brand names contain paclitaxel as their active ingredient composition:
Paclitax Nab 100mg Injection
Cipla Ltd
Paclitax 260mg Injection
Cipla Ltd
Mitotax 300mg Injection
Dr Reddy's Laboratories Ltd
Pacliaqualip 30mg Injection
Intas Pharmaceuticals Ltd
Abraxane
Bristol-Myers Squibb Pharma EEIG
Naveruclif
Accord Healthcare S.L.U.
Pazenir
ratiopharm GmbH
Apexelsin
Whiteoak Pharmaceutical B.V.
Apealea
Inceptua AB
Paxene
Norton Healthcare Ltd.
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
paclitaxel
Category
Antineoplastic agents
Manufacturer
Bristol-Myers Squibb Pharma EEIG
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.